1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with tretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladisch, S; Li, R | 1 |
| Imokawa, G; Sawada, E; Yoshida, N | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tretinoin
| Article | Year |
|---|---|
Inhibition of endogenous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells.
Topics: Down-Regulation; Enzyme Inhibitors; Gangliosides; Glucosyltransferases; Humans; Morpholines; Neurites; Neuroblastoma; Tretinoin; Tumor Cells, Cultured | 1997 |
A reconstructed human epidermal keratinization culture model to characterize ceramide metabolism in the stratum corneum.
Topics: Acid Ceramidase; Cell Culture Techniques; Cells, Cultured; Ceramides; Desipramine; Epidermis; Feasibility Studies; Gene Expression Regulation; Glucosylceramidase; Glucosyltransferases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inositol; Interleukin-1alpha; Keratinocytes; Models, Biological; Morpholines; Sphingolipids; Sphingomyelin Phosphodiesterase; Tretinoin | 2012 |